Annual Total Long Term Liabilities
$62.61 M
+$1.57 M+2.58%
December 31, 2024
Summary
- As of March 12, 2025, TSHA annual total long term liabilities is $62.61 million, with the most recent change of +$1.57 million (+2.58%) on December 31, 2024.
- During the last 3 years, TSHA annual total long term liabilities has fallen by -$4.21 million (-6.31%).
- TSHA annual total long term liabilities is now -6.31% below its all-time high of $66.83 million, reached on December 31, 2021.
Performance
TSHA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$62.61 M
+$527.00 K+0.85%
December 31, 2024
Summary
- As of March 12, 2025, TSHA quarterly total long term liabilities is $62.61 million, with the most recent change of +$527.00 thousand (+0.85%) on December 31, 2024.
- Over the past year, TSHA quarterly long term liabilities has stayed the same.
- TSHA quarterly long term liabilities is now -7.95% below its all-time high of $68.02 million, reached on June 30, 2023.
Performance
TSHA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TSHA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.6% | 0.0% |
| 3 y3 years | -6.3% | 0.0% |
| 5 y5 years | +100.0% | 0.0% |
TSHA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.3% | +2.6% | -8.0% | +9.2% |
| 5 y | 5-year | -6.3% | -100.0% | -8.0% | -100.0% |
| alltime | all time | -6.3% | -100.0% | -8.0% | -100.0% |
Taysha Gene Therapies Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $62.61 M(+2.6%) | $62.61 M(+0.8%) |
| Sep 2024 | - | $62.09 M(+8.3%) |
| Jun 2024 | - | $57.35 M(-5.2%) |
| Mar 2024 | - | $60.51 M(-0.9%) |
| Dec 2023 | $61.04 M(-2.4%) | $61.04 M(-5.3%) |
| Sep 2023 | - | $64.43 M(-5.3%) |
| Jun 2023 | - | $68.02 M(+9.5%) |
| Mar 2023 | - | $62.09 M(-0.7%) |
| Dec 2022 | $62.54 M | $62.54 M(-6.9%) |
| Sep 2022 | - | $67.20 M(+0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $66.67 M(+0.1%) |
| Mar 2022 | - | $66.63 M(-0.3%) |
| Dec 2021 | $66.83 M(>+9900.0%) | $66.83 M(+16.4%) |
| Sep 2021 | - | $57.43 M(+112.9%) |
| Jun 2021 | - | $26.97 M(+2600.1%) |
| Mar 2021 | - | $999.00 K(+122.0%) |
| Dec 2020 | $450.00 K(>+9900.0%) | - |
| Dec 2020 | - | $450.00 K(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00 |
| Dec 2019 | $0.00 | - |
FAQ
- What is Taysha Gene Therapies annual total long term liabilities?
- What is the all time high annual total long term liabilities for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual total long term liabilities year-on-year change?
- What is Taysha Gene Therapies quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly long term liabilities year-on-year change?
What is Taysha Gene Therapies annual total long term liabilities?
The current annual total long term liabilities of TSHA is $62.61 M
What is the all time high annual total long term liabilities for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual total long term liabilities is $66.83 M
What is Taysha Gene Therapies annual total long term liabilities year-on-year change?
Over the past year, TSHA annual total long term liabilities has changed by +$1.57 M (+2.58%)
What is Taysha Gene Therapies quarterly total long term liabilities?
The current quarterly long term liabilities of TSHA is $62.61 M
What is the all time high quarterly long term liabilities for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly total long term liabilities is $68.02 M
What is Taysha Gene Therapies quarterly long term liabilities year-on-year change?
Over the past year, TSHA quarterly total long term liabilities has changed by $0.00 (0.00%)